Wright GM - Search Results

1

Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors.

Rudin CM, Pandha HS, Zibelman M, Akerley WL, Harrington KJ, Day D, Hill AG, O'Day SJ, Clay TD, Wright GM, Jennens RR, Gerber DE, Rosenberg JE, Ralph C, Campbell DC, Curti BD, Merchan JR, Ren Y, Schmidt EV, Guttman L, Gupta S. Rudin CM, et al. Among authors: wright gm. J Immunother Cancer. 2023 Jan;11(1):e005007. doi: 10.1136/jitc-2022-005007. J Immunother Cancer. 2023. PMID: 36669791 Free PMC article. Clinical Trial.

2

Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancer.

Newnham GM, Conron M, McLachlan S, Dobrovic A, Do H, Li J, Opeskin K, Thompson N, Wright GM, Thomas DM. Newnham GM, et al. Among authors: wright gm. BMC Cancer. 2011 Mar 7;11:93. doi: 10.1186/1471-2407-11-93. BMC Cancer. 2011. PMID: 21385341 Free PMC article.

3

EGFR gene copy number alterations are not a useful screening tool for predicting EGFR mutation status in lung adenocarcinoma.

Russell PA, Yu Y, Do H, Clay TD, Moore MM, Wright GM, Conron M, Wainer Z, Dobrovic A, McLachlan SA. Russell PA, et al. Among authors: wright gm. Pathology. 2014 Jan;46(1):32-6. doi: 10.1097/PAT.0000000000000027. Pathology. 2014. PMID: 24300726

4

The clinical relevance of pathologic subtypes in metastatic lung adenocarcinoma.

Clay TD, Do H, Sundararajan V, Moore MM, Conron M, Wright GM, McLachlan SA, Dobrovic A, Russell PA. Clay TD, et al. Among authors: wright gm. J Thorac Oncol. 2014 May;9(5):654-63. doi: 10.1097/JTO.0000000000000150. J Thorac Oncol. 2014. PMID: 24722155 Free article.

5

Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations.

Clay TD, Russell PA, Do H, Sundararajan V, Conron M, Wright GM, Dobrovic A, Moore MM, McLachlan SA. Clay TD, et al. Among authors: wright gm. Pathology. 2016 Jan;48(1):17-24. doi: 10.1016/j.pathol.2015.11.002. Epub 2015 Dec 12. Pathology. 2016. PMID: 27020204

6

EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma.

Clay TD, Russell PA, Do H, Sundararajan V, Conron M, Wright GM, Solomon B, Dobrovic A, McLachlan SA, Moore MM. Clay TD, et al. Among authors: wright gm. Med Oncol. 2017 Sep 6;34(10):175. doi: 10.1007/s12032-017-1031-1. Med Oncol. 2017. PMID: 28879441

7

Complete resection of non-small-cell lung cancer and oligo-metastatic brain disease.

Daniels M, Wright GM. Daniels M, et al. Among authors: wright gm. ANZ J Surg. 2005 Nov;75(11):963-6. doi: 10.1111/j.1445-2197.2005.03585.x. ANZ J Surg. 2005. PMID: 16336388

8

Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials.

Wright G, Manser RL, Byrnes G, Hart D, Campbell DA. Wright G, et al. Thorax. 2006 Jul;61(7):597-603. doi: 10.1136/thx.2005.051995. Epub 2006 Jan 31. Thorax. 2006. PMID: 16449262 Free PMC article. Review.

9

Molecular profiling of non-small cell lung cancer: of what value in clinical practice?

Newnham GM, Thomas DM, McLachlan SA, Wright G, Conron M. Newnham GM, et al. Among authors: wright g. Heart Lung Circ. 2008 Dec;17(6):451-62. doi: 10.1016/j.hlc.2007.11.144. Epub 2008 Jul 26. Heart Lung Circ. 2008. PMID: 18676201 Review.

10

Interobserver agreement in determining non-small cell lung cancer subtype in specimens acquired by EBUS-TBNA.

Steinfort DP, Russell PA, Tsui A, White G, Wright G, Irving LB. Steinfort DP, et al. Eur Respir J. 2012 Sep;40(3):699-705. doi: 10.1183/09031936.00109711. Epub 2012 Feb 9. Eur Respir J. 2012. PMID: 22323573 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

256 results

Search Page